{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30741932", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "12"}, "DateRevised": {"Year": "2020", "Month": "03", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "11"}], "Language": ["eng"], "ELocationID": ["117", "10.1038/s41419-019-1363-1"], "Journal": {"ISSN": "2041-4889", "JournalIssue": {"Volume": "10", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Feb", "Day": "11"}}, "Title": "Cell death & disease", "ISOAbbreviation": "Cell Death Dis"}, "ArticleTitle": "Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.", "Pagination": {"StartPage": "117", "MedlinePgn": "117"}, "Abstract": {"AbstractText": ["The ETS transcription factor Fli-1 controls the expression of genes involved in hematopoiesis including cell proliferation, survival, and differentiation. Dysregulation of Fli-1 induces hematopoietic and solid tumors, rendering it an important target for therapeutic intervention. Through high content screens of a library of chemicals isolated from medicinal plants in China for inhibitors of a Fli-1 transcriptional reporter cells, we hereby report the identification of diterpenoid-like compounds that strongly inhibit Fli-1 transcriptional activity. These agents suppressed the growth of erythroleukemic cells by inducing apoptosis and differentiation. They also inhibited survival and proliferation of B-cell leukemic cell lines as well as primary B-cell lymphocytic leukemia (B-CLL) isolated from 7 patients. Moreover, these inhibitors blocked leukemogenesis in a mouse model of erythroleukemia, in which Fli-1 is the driver of tumor initiation. Computational docking analysis revealed that the diterpenoid-like compounds bind with high affinity to nucleotide residues in a pocket near the major groove within the DNA-binding sites of Fli-1. Functional inhibition of Fli-1 by these compounds triggered its further downregulation through miR-145, whose promoter is normally repressed by Fli-1. These results uncover the importance of Fli-1 in leukemogenesis, a Fli-1-miR145 autoregulatory loop and new anti-Fli-1 diterpenoid agents for the treatment of diverse hematological malignancies overexpressing this transcription factor."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Liu", "ForeName": "Tangjingjun", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Xia", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Yao", "ForeName": "Yao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China."}], "LastName": "Yan", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Fan", "ForeName": "Yanhua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China."}], "LastName": "Yang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, Norman Bethune College of Medicine, Jilin University, Changchun, China."}], "LastName": "Li", "ForeName": "You-Jun", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, Norman Bethune College of Medicine, Jilin University, Changchun, China."}, {"Identifier": [], "Affiliation": "Biology Platform, Sunnybrook Research Institute, Toronto, Canada."}], "LastName": "Chen", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biology Platform, Sunnybrook Research Institute, Toronto, Canada."}], "LastName": "Filmus", "ForeName": "Jorge", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biology Platform, Sunnybrook Research Institute, Toronto, Canada."}], "LastName": "Spaner", "ForeName": "David E", "Initials": "DE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, Ontario, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute-University Health Network, Toronto, Ontario, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China. haoxj@mail.kib.ac.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China. haoxj@mail.kib.ac.cn."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China. haoxj@mail.kib.ac.cn."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550025, China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, 550014, China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Death Dis", "NlmUniqueID": "101524092"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN145 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Protein c-fli-1"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Small Interfering"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["drug effects"], "DescriptorName": "Carcinogenesis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "DNA"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Diterpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kaplan-Meier Estimate"}, {"QualifierName": ["drug therapy", "mortality", "pathology"], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Tertiary"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}, {"QualifierName": [], "DescriptorName": "RNA Interference"}, {"QualifierName": ["metabolism", "therapeutic use"], "DescriptorName": "RNA, Small Interfering"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904\u20135912. doi: 10.1038/onc.2008.271.", "ArticleIdList": ["10.1038/onc.2008.271", "PMC3689267", "18836471"]}, {"Citation": "Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991;66:831\u2013834. doi: 10.1016/0092-8674(91)90428-2.", "ArticleIdList": ["10.1016/0092-8674(91)90428-2", "1889087"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification of a common proviral integration site in erythroleukemic cells induced by Friend Murine Leukemia Virus (F-MuLV) Proc. Natl. Acad. Sci. U. S. A. 1990;87:1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Tamir A, et al. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol. Cell Biol. 1999;19:4452\u20134464. doi: 10.1128/MCB.19.6.4452.", "ArticleIdList": ["10.1128/MCB.19.6.4452", "PMC104404", "10330185"]}, {"Citation": "Delattre O, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162\u2013165. doi: 10.1038/359162a0.", "ArticleIdList": ["10.1038/359162a0", "1522903"]}, {"Citation": "Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y. The ets transcription factor Fli-1 in development, cancer and disease. Oncogene. 2015;34:2022\u20132031. doi: 10.1038/onc.2014.162.", "ArticleIdList": ["10.1038/onc.2014.162", "PMC5028196", "24909161"]}, {"Citation": "Lennard RML, Nowling TK, Brandon D, Watson DK, Zhang XK. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol. Immunol. 2015;63:566\u2013573. doi: 10.1016/j.molimm.2014.07.013.", "ArticleIdList": ["10.1016/j.molimm.2014.07.013", "PMC4254164", "25108845"]}, {"Citation": "Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009;23:1311\u20131319. doi: 10.1038/leu.2009.20.", "ArticleIdList": ["10.1038/leu.2009.20", "19282832"]}, {"Citation": "Li YJ, et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Grohar PJ, et al. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J. Natl. Cancer Inst. 2011;103:962\u2013978. doi: 10.1093/jnci/djr156.", "ArticleIdList": ["10.1093/jnci/djr156", "PMC3119649", "21653923"]}, {"Citation": "Erkizan HV, et al. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing\u2019s sarcoma. Nat. Med. 2009;15:750\u2013756. doi: 10.1038/nm.1983.", "ArticleIdList": ["10.1038/nm.1983", "PMC2777681", "19584866"]}, {"Citation": "Grohar PJ, et al. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia. 2011;13:145\u2013153. doi: 10.1593/neo.101202.", "ArticleIdList": ["10.1593/neo.101202", "PMC3033593", "21403840"]}, {"Citation": "Boro A, et al. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing\u2019s sarcoma. Int. J. Cancer. 2012;131:2153\u20132164. doi: 10.1002/ijc.27472.", "ArticleIdList": ["10.1002/ijc.27472", "22323082"]}, {"Citation": "Wang W, Liu H, Wang S, Hao X, Li L. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/beta-catenin signaling and colon cancer cell tumorigenesis. Cell Res. 2011;21:730\u2013740. doi: 10.1038/cr.2011.30.", "ArticleIdList": ["10.1038/cr.2011.30", "PMC3203668", "21321609"]}, {"Citation": "Liu T, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8:16728\u201316743.", "ArticleIdList": ["PMC5369997", "28052010"]}, {"Citation": "Barbeau B, Barat C, Bergeron D, Rassart E. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1. Oncogene. 1999;18:5535\u20135545. doi: 10.1038/sj.onc.1202913.", "ArticleIdList": ["10.1038/sj.onc.1202913", "10523830"]}, {"Citation": "Barbeau B, Bergeron D, Beaulieu M, Nadjem Z, Rassart E. Characterization of the human and mouse Fli-1 promoter regions. Biochim. Biophys. Acta. 1996;1307:220\u2013232. doi: 10.1016/0167-4781(96)00060-7.", "ArticleIdList": ["10.1016/0167-4781(96)00060-7", "8679708"]}, {"Citation": "Lakhanpal GK, et al. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood. 2010;116:428\u2013436. doi: 10.1182/blood-2009-10-250217.", "ArticleIdList": ["10.1182/blood-2009-10-250217", "20445019"]}, {"Citation": "Kanaji S, et al. Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation. Blood. 2005;105:3888\u20133892. doi: 10.1182/blood-2004-08-3109.", "ArticleIdList": ["10.1182/blood-2004-08-3109", "PMC1895081", "15701720"]}, {"Citation": "Moussa O, et al. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol. Cell Biol. 2010;30:5194\u20135206. doi: 10.1128/MCB.01112-09.", "ArticleIdList": ["10.1128/MCB.01112-09", "PMC2953061", "20823267"]}, {"Citation": "Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia. 2000;14:439\u2013445. doi: 10.1038/sj.leu.2401689.", "ArticleIdList": ["10.1038/sj.leu.2401689", "10720139"]}, {"Citation": "Vecchiarelli-Federico LM, et al. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect. Int J. Oncol. 2017;51:456\u2013466. doi: 10.3892/ijo.2017.4027.", "ArticleIdList": ["10.3892/ijo.2017.4027", "PMC5505126", "28586009"]}, {"Citation": "Anantharaman A, et al. Role of helix-loop-helix proteins during differentiation of erythroid cells. Mol. Cell Biol. 2011;31:1332\u20131343. doi: 10.1128/MCB.01186-10.", "ArticleIdList": ["10.1128/MCB.01186-10", "PMC3135301", "21282467"]}, {"Citation": "Hou C, et al. Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1. Nucleic Acids Res. 2016;44:8990\u20139004. doi: 10.1093/nar/gkw761.", "ArticleIdList": ["10.1093/nar/gkw761", "PMC5063001", "27587584"]}, {"Citation": "Wu P, et al. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1. Oncotarget. 2016;7:42241\u201342251.", "ArticleIdList": ["PMC5173131", "27304058"]}, {"Citation": "Zhang J, et al. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer. 2011;117:86\u201395. doi: 10.1002/cncr.25522.", "ArticleIdList": ["10.1002/cncr.25522", "PMC2995010", "20737575"]}, {"Citation": "Larsson E, et al. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009;1:108. doi: 10.1186/gm108.", "ArticleIdList": ["10.1186/gm108", "PMC2808743", "19917099"]}, {"Citation": "Ban J, et al. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing\u2019s sarcoma. Oncogene. 2011;30:2173\u20132180. doi: 10.1038/onc.2010.581.", "ArticleIdList": ["10.1038/onc.2010.581", "PMC4959567", "21217773"]}, {"Citation": "Bradshaw S, Zheng WJ, Tsoi LC, Gilkeson G, Zhang XK. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin. Immunol. 2008;129:19\u201330. doi: 10.1016/j.clim.2008.05.010.", "ArticleIdList": ["10.1016/j.clim.2008.05.010", "PMC2562591", "18692443"]}, {"Citation": "Howard JC, Yousefi S, Cheong G, Bernstein A, Ben-David Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8:2721\u20132729.", "ArticleIdList": ["8378083"]}, {"Citation": "Ma Y, et al. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J. Cancer. 2012;130:2077\u20132087. doi: 10.1002/ijc.26232.", "ArticleIdList": ["10.1002/ijc.26232", "21671476"]}, {"Citation": "Zhang X, Wu J. Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis. Prostate Int. 2015;3:71\u201374. doi: 10.1016/j.prnil.2014.09.001.", "ArticleIdList": ["10.1016/j.prnil.2014.09.001", "PMC4588372", "26473147"]}, {"Citation": "Teoh SL, Das S. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer. Curr. Pharm. Des. 2017;23:1845\u20131859. doi: 10.2174/1381612822666161027120043.", "ArticleIdList": ["10.2174/1381612822666161027120043", "28231756"]}, {"Citation": "Wang S, et al. microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer. JCI Insight. 2017;2:e93313. doi: 10.1172/jci.insight.93313.", "ArticleIdList": ["10.1172/jci.insight.93313", "PMC5543917", "28768903"]}, {"Citation": "Zhao N, et al. MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. Circ. Res. 2015;116:23\u201334. doi: 10.1161/CIRCRESAHA.115.303970.", "ArticleIdList": ["10.1161/CIRCRESAHA.115.303970", "PMC4299754", "25323858"]}, {"Citation": "Sakurai T, et al. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci. 2007;98:1775\u20131784. doi: 10.1111/j.1349-7006.2007.00598.x.", "ArticleIdList": ["10.1111/j.1349-7006.2007.00598.x", "17727680"]}, {"Citation": "Li Y, et al. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood. 2012;119:4486\u20134498. doi: 10.1182/blood-2011-09-378687.", "ArticleIdList": ["10.1182/blood-2011-09-378687", "22451425"]}, {"Citation": "Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137:647\u2013658. doi: 10.1016/j.cell.2009.02.038.", "ArticleIdList": ["10.1016/j.cell.2009.02.038", "19409607"]}, {"Citation": "Morris GM, et al. Auto-Dock 4 and AutoDockTools 4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}]}], "History": [{"Year": "2018", "Month": "8", "Day": "16"}, {"Year": "2019", "Month": "1", "Day": "9"}, {"Year": "2019", "Month": "1", "Day": "9"}, {"Year": "2019", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["30741932", "PMC6370842", "10.1038/s41419-019-1363-1", "10.1038/s41419-019-1363-1"]}}]}